XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Assets:    
Cash $ 21,336 $ 111,255
Accounts receivable 200,000
Prepaid expenses, deposits, and other current assets 2,283,164 1,328,624
Total current assets 2,504,500 1,439,879
Other assets 791,812 755,000
Total assets 3,296,312 2,194,879
Current liabilities:    
Accounts payable 2,840,505 2,057,574
Accrued expenses and other current liabilities 307,533 394,209
Due To: PAVmed Inc. - Senior Unsecured Promissory Note - Principal 22,400,000
Due To: PAVmed Inc. - MSA Fee, operating expenses, and interest expense 1,882,467 13,261,435
Total liabilities 27,430,505 15,713,218
Commitments and contingencies (Note 8)
Stockholders’ Equity (Deficit):    
Preferred stock, $0.001 par value, 20,000,000 shares authorized; no shares issued and outstanding as of September 30, 2021 and December 31, 2020
Common stock, $0.001 par value, 100,000,000 shares authorized; 14,114,707 shares issued and outstanding as of September 30, 2021 and December 31, 2020 14,115 14,115
Additional paid-in capital 6,450,060 293,521
Accumulated deficit (30,598,368) (13,825,975)
Total Stockholders’ (Deficit) (24,134,193) (13,518,339)
Total Liabilities and Stockholders’ Equity (Deficit) $ 3,296,312 $ 2,194,879